Revision Skincare, a well-known pioneer in advanced physician-dispensed skincare products, has hired Lisa Paley as its new Chief Executive Officer. With close to three decades of consumer healthcare and wellness experience, Paley will drive the company into its next growth phase, emphasizing innovation, international expansion, and solidifying Revision Skincare’s position as a respected science-driven skincare leader.
Paley comes to Revision Skincare from Haleon, the global leader in consumer health, where she held the role of President of North America and was a member of the founding Executive Leadership Team. Throughout her time at Haleon, she was instrumental in driving the company’s spin from GlaxoSmithKline (GSK) and subsequent successful public floats on both the New York Stock Exchange (NYSE) and the Financial Times Stock Exchange (FTSE). Her background in leadership spans managing high-volume operations, leading brand growth, and executing strategic programs to improve business performance.
Before joining Haleon, Paley served in various senior leadership roles at GSK Consumer Healthcare, a joint entity with Pfizer, where she concentrated on creating and growing consumer health brands. She was also President of North America at Pfizer Consumer Healthcare, managing businesses in the U.S., Canada, and the Caribbean. Early in her professional life, Paley started as a Certified Public Accountant at Deloitte and subsequently took leadership positions at Johnson & Johnson, providing her with a robust finance, operations, and corporate strategy background.
As the new CEO of Revision Skincare, Paley intends to build on the firm’s solid background in scientific innovation to provide life-changing skincare solutions for both professionals and consumers. She has reinforced her dedication to blending health and beauty trends, creating products that marry clinical effectiveness with consumer acceptance. Paley’s plan is to build Revision Skincare’s position in important markets around the globe, deepen relationships with dermatologists and skin care professionals, and further establish the company as a recognized leader in high-quality, science-driven skincare.
Revision Skincare has been backed solidly by private equity sponsor Gryphon Investors, which sees Paley’s hiring as a key move to fuel the company’s next phase of growth. Matt Farron, Partner and Co-Head of Gryphon Investors’ Consumer Group, said, “Lisa’s significant background developing science-driven brands along the consumer health, wellness, and beauty continuum makes her the perfect leader to drive our business in the U.S. and other key markets.” This goes to show the trust that is being placed in Paley to implement strategic growth strategies and grow the company’s market penetration.
Paley’s leadership has also been known to encourage innovation and empower teams to drive results. She has a track record for driving operational excellence, enhancing brand positioning, and making strategic decisions based on data-driven insights. Her appointment is a move that comes in line with Revision Skincare’s vision to continue being at the top of the skincare industry while staying committed to quality, efficacy, and professional trust.
In addition to her business accomplishments, Paley has had a very active role in industry and professional associations. She was formerly Chairman of the Board of Consumer Healthcare Products Association (CHPA) and chaired the National Association of Chain Drug Stores (NACDS) Retail Advisory Board. In addition, she has served on the boards of NextUp, Excel Share Group, and WE, which have the mandates of empowering women and increasing opportunities for leadership in consumer health and wellness industries. These roles reflect her interest in inclusive leadership and career growth, which she is likely to bring to Revision Skincare’s organizational culture.
Founded in 1984 and based in Irving, Texas, Revision Skincare is dedicated to creating effective, high-performance skincare products that deliver tangible results. The company’s product portfolio ranges from a variety of solutions tailored to treat varied skin issues, such as aging and pigmentation through hydration and sun protection. Through an emphasis on innovation, clinical research, and professional support, Revision Skincare has emerged as a highly respected brand among dermatologists and skincare professionals globally.
With Lisa Paley leading Revision Skincare, the company is well-positioned to build on its trend of growth and innovation. Her background in consumer health, along with a strong knowledge of international markets and operational management, makes her uniquely qualified to lead significant growth and affirm the company as an industry leader in professional skincare. Paley’s hire indicates a renewed emphasis on providing science-driven, high-quality skincare solutions while building the company’s global presence and impact.
Paley’s leadership holds the potential to bring a new era to Revision Skincare, one that combines innovation, professional credibility, and international expansion. As she assumes her position as CEO, the industry and customers will be keenly observing, waiting to see how her vision and knowledge will guide one of the world’s top skincare firms into the future.
